Neuro-Oncology Reviews
Volume
27 Number 32
20 November 2025
Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 32, 20 November
Shida D.
Editorial: Brain Metastases
(Secondary Brain Tumor).
Cancers
(Basel). 2025 Oct 27;17(21):3440. doi:
10.3390/cancers17213440. PMID:
41228233. Editorial. ˍ
Nizamutdinov D, Sentmanat A, Tong J, Qi X, Pan Y, Qi D, Wu E,
Huang JH.
The Emerging Role of
Oncolytic Virotherapy in Glioblastoma Management.
Cancers
(Basel). 2025 Oct 28;17(21):3465. doi:
10.3390/cancers17213465. PMID:
41228258. Review. ˍ
Emeny RT, Butow ME, Titus L, Ricci AM, Bagley PJ, Blunt HB, Morgan
A, Alford-Teaster JA, Walston RR 3rd, Rees JR.
Causes
of Childhood Cancer: A Literature Review (2014-2021)-Part 3:
Environmental and Occupational Factors.
Cancers
(Basel). 2025 Oct 31;17(21):3516. doi:
10.3390/cancers17213516. PMID:
41228305. Review. ˍ
Bagchi A, Chiang J, Pinto S, Dhanda S, Gajjar A.
Infant-Type
Hemispheric Gliomas: A Review of Clinical, Radiologic,
Histopathologic, and Molecular Features.
J
Natl Compr Canc Netw. 2025 Nov 1;23(11):e257064. doi:
10.6004/jnccn.2025.7064. PMID:
41213248. Review. ˍ
Mittelman L, Duehr J, Kazmi JS, Vargas LO, Donahue N, Chen J,
Leskinen S, Syed SA, Wernicke AG, D'Amico RS.
Radiation
Necrosis in Neuro-Oncology: Diagnostic Complexity and Precision
Radiotherapy Strategies.
Cancers
(Basel). 2025 Nov 1;17(21):3542. doi:
10.3390/cancers17213542. PMID:
41228337. Review. ˍ
Nowacka A, Śniegocki M, Bożiłow D, Ziółkowska
E.
Gut Microbiota and Central Nervous
System Tumors: A Comprehensive Systematic Review and Meta-Analysis
of Microbiome-CNS Interactions.
Int
J Mol Sci. 2025 Nov 4;26(21):10721. doi:
10.3390/ijms262110721. PMID:
41226760. Review; Meta-Analysis. ˍ
Xu M, An Y, Liu X, Li X, Huang X, Gu Q, Xue M, Xue J, Tao L, Shan
H, Chen X, Zhang M.
The molecular
mechanisms of cuproptosis and its role in central nervous system
diseases.
Cell
Signal. 2025 Nov 10;138:112236. doi:
10.1016/j.cellsig.2025.112236. PMID:
41224164. Review˰
ˍ
Ge Z, Jin G, Wang H, Wang S, Fei X, Li S, Zhang L, Jiang X, Zhang
Y.
Risk factors for postoperative
malignant progression of lower-grade gliomas: a systematic review
and meta-analysis.
Surg
Oncol. 2025 Nov 12;64:102327. doi:
10.1016/j.suronc.2025.102327. PMID:
41242200. Review;
Meta-Analysis˰
ˍ
Basaran AE, Wellkisch AC, Güresir E, Wach J.
Extent
of reoperation predicts survival in recurrent IDH-wildtype
glioblastoma based on institutional data and individual patient
data meta analysis.
Discov
Oncol. 2025 Nov 13;16(1):2099. doi:
10.1007/s12672-025-03928-8. PMID:
41231323. Meta analysis. ˍ
Pristo EL, Hotchkiss KM, Corcoran AM, Noldner P, Okada H, Hickey
JW, Conejo-Garcia J, Shaz B, Khasraw M.
The
promise of TIL therapy for glioblastoma.
Trends
Cancer. 2025 Nov 13:S2405-8033(25)00254-7. doi:
10.1016/j.trecan.2025.10.003. PMID:
41238472. Review˰
ˍ
Huang M, Li J, Liu B, Liao Y, Wang B, Liu H, Liu Y, Zhao J.
Non-WNT/non-SHH medulloblastoma in
siblings: case report and literature review.
Discov
Oncol. 2025 Nov 20. doi:
10.1007/s12672-025-04038-1. PMID:
41264133. Case report; Review. ˍ
Santos MDC, Rodrigues NMV, Gibram F, Gouhie FA, Campos ACP, de
Assis DV, Formentin C, Feher O, de Souza E Silva ARN, Hanna SA,
Chung C, Barbosa CC, Moraes FY, Maldaun MVC.
Adjuvant
chemoradiotherapy with procarbazine, lomustine, and vincristine
(PCV) or temozolomide for 1p/19q Co-deleted anaplastic
oligodendroglioma: a systematic review and network meta-analysis.
BMC
Cancer. 2025 Nov 18;25(1):1779. doi:
10.1186/s12885-025-15085-w. PMID:
41254593. Review; Meta-Analysis.
ˍ
Fawzy M, ElTayebi HM, Samir A.
Exploring
Neural Stem Cell Therapies as Innovative Treatments for
Glioblastoma.
Cell
Mol Neurobiol. 2025 Nov 20;45(1):108. doi:
10.1007/s10571-025-01619-0. PMID:
41264121. Review. ˍ
Mezzari MHDS, Lima NL, Maggi BG, Grüdtner DOM, de Souza JCS,
de Lara LHC, Isolan GR.
Regorafenib in
adult patients with recurrent glioblastoma: a single-arm
meta-analysis.
J
Chemother. 2025 Nov 20:1-12. doi:
10.1080/1120009X.2025.2591474. PMID:
41263675. Meta
analysis˰ ˍ